We are live on ! Find out more
STDY

SteadyMed Ltd
STDY

Delisted

STDY was delisted on the 29th of August, 2018.

Back to rankings

5 hedge funds and large institutions have $764K invested in SteadyMed Ltd in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less funds holding

Funds holding: 30 → 5 (-25)

96% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 26

99% less capital invested

Capital invested by funds: $52.3M → $764K (-$51.6M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-25
Holders Change %
-83.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AGM
Alpine Global Management
New York
+$590K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$19.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$8.55M
3
DM
Deerfield Management
New York
-$4.13M
4
CS
Credit Suisse
Switzerland
-$3.19M
5
Man Group
Man Group
United Kingdom
-$3.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
AGM
1
Alpine Global Management
New York
$591K +$590K +126,500 New
AP
2
Appleton Partners
Massachusetts
$105K – – –
HCMT
3
Highland Capital Management (Tennessee)
Tennessee
$45K – – –
TRCT
4
Tower Research Capital (TRC)
New York
$18K -$2.42K -519 -12%
TCOV
5
Trust Company of Vermont
Vermont
$5K – – –
O
6
OrbiMed
New York
– -$19.1M -4,246,196 Closed
Federated Hermes
7
Federated Hermes
Pennsylvania
– -$8.55M -2,024,936 Closed
DM
8
Deerfield Management
New York
– -$4.13M -918,120 Closed
CS
9
Credit Suisse
Switzerland
– -$3.19M -710,098 Closed
Man Group
10
Man Group
United Kingdom
– -$3.19M -710,098 Closed
KCM
11
Kingdon Capital Management
New York
– -$2.26M -503,140 Closed
AC
12
Armistice Capital
New York
– -$2.24M -497,044 Closed
TP
13
Truvvo Partners
New York
– -$1.68M -373,369 Closed
Renaissance Technologies
14
Renaissance Technologies
New York
– -$1.34M -298,562 Closed
EIM
15
Essex Investment Management
Massachusetts
– -$1.16M -256,790 Closed
SG Americas Securities
16
SG Americas Securities
New York
– -$1.1M -245,429 Closed
MCM
17
Moore Capital Management
New York
– -$1.01M -225,000 Closed
YCM
18
Yakira Capital Management
Connecticut
– -$765K -170,000 Closed
HCMT
19
Highland Capital Management (Texas)
Texas
– -$492K -109,498 Closed
CL
20
CSS LLC
Illinois
– -$470K -104,535 Closed
WSL
21
Western Standard LLC
California
– -$385K -85,523 Closed
Deutsche Bank
22
Deutsche Bank
Germany
– -$361K -80,300 Closed
MC
23
Menta Capital
California
– -$279K -62,108 Closed
VF
24
Virtu Financial
New York
– -$97K -21,652 Closed
LTFS
25
Ladenburg Thalmann Financial Services
Florida
– -$52K -16,050 Closed
1
2

STDY Hedge Fund Activity: Q3 2018 in Review

5 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in SteadyMed Ltd (STDY) for Q3 2018, worth a combined $764K — down 99% from $52.3M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of STDY and 1 opened new positions — a net loss of 25 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was Alpine Global Management, opening a new position worth an estimated $590K. The largest seller was OrbiMed, exiting entirely with an estimated $19.1M sold.

  • 5 institutional investors held SteadyMed Ltd (STDY) as of Q3 2018, down from 30 in Q2 2018.
  • Funds reported $764K of SteadyMed Ltd stock for Q3 2018, down 99% quarter-over-quarter.
  • 1 fund opened new SteadyMed Ltd positions in Q3 2018 and 26 closed out, a net change of -25 holders.
  • The largest SteadyMed Ltd buyer in Q3 2018 was Alpine Global Management, an estimated $590K added.
  • The largest SteadyMed Ltd seller in Q3 2018 was OrbiMed, an estimated $19.1M sold.

Based on aggregated 13F filings for Q3 2018.